KWAR23, an anti-human SIRPalpha antibody, exhibits high-affinity binding to human SIRPalpha, inhibiting its interaction with CD47. Demonstrating antitumor activity, KWAR23 is efficacious in conjunction with tumor-opsonizing antibodies, making it a valuable agent
CAS Number:
[2243227-60-1]
* VAT and and shipping costs not included. Errors and price changes excepted